Filed: 2/13/2026ACC: 0001193125-26-051393
📋 What this filing means
COLUMN GROUP LLC filed this quarterly 13F‑HR report disclosing 5 equity positions with a total reported market value of $82.79M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
5
Positions
$82.79M
Total AUM (reported)
14.95M
Total Shares
Allocation by class
COM$82.79M100.0%
Portfolio Concentration
Top 3$77.50M93.6%
4–10$5.30M6.4%
Top 3 weight
93.6%
Top 10 weight
100.0%
Voting Authority Distribution
Total shares with voting rights: 14.95M
Sole
Full voting authority
14.95M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole5
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings5
Rows:
Surrozen, Inc.
SOLEShares1.85M
TypeSH
Market value$41.84M
50.54%
Sole
1.85M
Shared
0.00
None
0.00
ORIC Pharmaceuticals Inc.
SOLEShares3.54M
TypeSH
Market value$28.96M
34.98%
Sole
3.54M
Shared
0.00
None
0.00
Tenaya Therapeutics, Inc.
SOLEShares9.40M
TypeSH
Market value$6.69M
8.08%
Sole
9.40M
Shared
0.00
None
0.00
RAPT Therapeutics Inc
SOLEShares156.27K
TypeSH
Market value$5.29M
6.39%
Sole
156.27K
Shared
0.00
None
0.00
Revolution Medicines Inc
SOLEShares46.00
TypeSH
Market value$3.7K
<0.01%
Sole
46.00
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
Surrozen, Inc.SOLE | COM | 1.85M | SH | $41.84M 50.54% | 1.85M | 0.00 | 0.00 |
ORIC Pharmaceuticals Inc.SOLE | COM | 3.54M | SH | $28.96M 34.98% | 3.54M | 0.00 | 0.00 |
Tenaya Therapeutics, Inc.SOLE | COM | 9.40M | SH | $6.69M 8.08% | 9.40M | 0.00 | 0.00 |
RAPT Therapeutics IncSOLE | COM | 156.27K | SH | $5.29M 6.39% | 156.27K | 0.00 | 0.00 |
Revolution Medicines IncSOLE | COM | 46.00 | SH | $3.7K <0.01% | 46.00 | 0.00 | 0.00 |